Europe Injectable Drug Delivery Market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market.
Pune, India -- (SBWIRE) -- 07/11/2018 -- According to Data Bridge Market Research new market report "Europe Injectable Drug Delivery Market By Type {Devices (Conventional, Self), Formulations (Conventional, Noble, Long Acting)} Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology) Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System) End User (Hospitals, Clinics, Home Care Settings, Research Laboratories) Country (Germany, France, U.K., Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherlands, and Rest of Europe) – Industry Trends and Forecast to 2024"
Ask for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-injectable-drug-delivery-market
Market Segmentation:
The Europe injectable drug delivery market is segmented based on type, applications, usage pattern, mode of administration, end-user, and geography.
Based on type, the europe injectable drug delivery market is segmented into devices and formulations.
By product, the needle free injectors are further segmented into fillable needle-free injectors and prefilled needle-free injectors.
On the basis of applications, the Europe injectable drug delivery market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others.
Based on indications, the europe injectable drug delivery market is segmented into rheumatoid arthritis, multiple sclerosis, Crohn's disease, psoriasis, and others.
Based on mode of administration, the europe injectable drug delivery market is segmented into skin, circulatory, organs, and central nervous system.
On the basis of usage pattern, the market is segmented into curative care, immunization, and others.
On the basis of end user, the market is segmented into hospitals, clinics, home care settings, research laboratories, and pharma and biotech companies.
Reasons to Purchase this Report
Current and future of europe injectable drug delivery market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Questions? Ask to Our Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-injectable-drug-delivery-market
TABLE OF CONTENTS EUROPE INJECTABLE DRUG DELIVERY MARKET
1. INTRODUCTION
1.1. OVERVIEW OF EUROPE INJECTABLE DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING CASES OF CHRONIC DISEASES
3.1.2. RISING DEMAND OF SELF-INJECTION DEVICES
3.1.3. GROWTH OF BIOLOGICS MARKET
3.1.4. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS IN DRUG DELIVERY MARKET
3.2. RESTRAINTS
3.2.1. NEEDLESTICK INJURIES AND INFECTIONS
3.2.2. HIGH COST OF DEVELOPMENT
3.2.3. STRICT REGULATORY FRAMEWORK
3.3. OPPORTUNITY
3.3.1. INCREASING DEMAND FOR GENERIC AND BIOSIMILAR DRUGS
3.3.1.1. GENERICS
3.3.1.2. BIOSIMILARS
3.3.2. INCREASING DEMAND FOR CONTRACEPTIVE INJECTABLES
3.3.3. INCREASING DEMAND FOR SELF-ADMINISTRATION OF DRUGS
3.4. CHALLENGES
3.4.1. ALTERNATIVE ROUTE OF DRUG ADMINISTRATION
3.4.2. PRODUCT RECALL
3.4.3. STABILITY OF PRODUCTS
3.4.4. STERILITY OF INJECTIONS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. EUROPE INJECTABLE DRUG DELIVERY MARKET, REGULATORY
6.1. OVERVIEW
6.2. U.S. FDA APPROVAL
6.3. CE MARKING (EUROPEAN CONFORMITY)
6.4. EM (EUROPEAN MEDICINE AGENCY)
7. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY TYPE
7.1. OVERVIEW
7.2. INJECTABLE DRUG DELIVERY DEVICES
7.2.1. CONVENTIONAL INJECTION DEVICES
7.2.2. SELF INJECTION DEVICES
7.2.2.1. NEEDLE FREE INJECTORS (NFI)
7.2.2.2. AUTO INJECTORS
7.2.2.3. PEN INJECTORS
7.2.2.4. WEARABLE INJECTORS
7.3. INJECTABLE DRUG DELIVERY FORMULATION
7.3.1. CONVENTIONAL DRUG DELIVERY FORMULATIONS
7.3.1.1. SOLUTIONS
7.3.1.2. RECONSTITUTED/LYOPHILIZED FORMULATIONS
7.3.1.3. SUSPENSIONS
7.3.1.4. EMULSIONS
7.3.2. NOVEL DRUG DELIVERY FORMULATIONS
7.3.2.1. COLLOIDAL DISPERSIONS
7.3.2.2. MICROPARTICLES
7.3.2.3. LONG ACTING INJECTION FORMULATION
8. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.1. OVERVIEW
8.2. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY APPLICATION
8.3. HORMONAL DISORDERS
8.3.1. INJECTABLE DRUGS FOR DIABETES
8.3.2. INJECTABLE DRUGS FOR ANEMIA
8.3.3. INJECTABLE DRUGS FOR REPRODUCTIVE HEALTH DISEASE
8.3.4. INJECTABLE DRUGS FOR ANTITHROMBOTIC/THROMBOLYTIC THERAPY
8.3.5. INJECTABLE DRUGS FOR OSTEOPOROSIS
8.3.6. INJECTABLE DRUGS FOR GROWTH HORMONE DISORDERS (GHD)
8.4. ONCOLOGY
8.5. AUTOIMMUNE DISEASES
8.5.1. INJECTABLE DRUGS FOR RHEUMATOID ARTHRITIS
8.5.2. INJECTABLE DRUGS FOR MULTIPLE SCLEROSIS
8.5.3. INJECTABLE DRUGS FOR CROHN'S DISEASES
8.5.4. INJECTABLE DRUGS FOR PSORIASIS
8.5.5. INJECTABLE DRUGS FOR OTHER AUTOIMMUNE DISEASES
8.6. ORPHAN DISEASE
8.7. OTHER APPLICATIONS
8.7.1. INJECTABLE DRUGS FOR PAIN MANAGEMENT
8.7.2. INJECTABLE DRUGS FOR ALLERGY TREATMENT
8.7.3. INJECTABLE DRUGS FOR AESTHETIC TREATMENTS
8.7.4. INJECTABLE DRUGS FOR HEPATITIS C
8.7.5. INJECTABLE DRUGS FOR HEMOPHILIA
9. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN
9.1. OVERVIEW
9.2. CURATIVE CARE
9.3. IMMUNIZATIONS
9.4. OTHER USAGE PATTERN
10. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY MODE OF ADMINISTRATION
10.1. OVERVIEW
10.2. SKIN
10.3. CIRCULATORY/ MUSKOSKELETAL
10.4. ORGANS
10.5. CENTRAL NERVOUS SYSTEM
11. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY END USER
11.1. OVERVIEW
11.2. HOSPITALS AND CLINICS
11.3. HOME HEALTHCARE SETTINGS
11.4. RESEARCH LABORATORIES
11.5. PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES
11.6. OTHER END USERS
12. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
12.1. OVERVIEW
12.1.1. HOSPITAL PHARMACY
12.1.2. PHARMACY STORES
12.1.3. DIRECT TENDER
12.1.4. ONLINE PHARMACY
13. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY GEOGRAPHY
13.1. OVERVIEW
13.2. EUROPE INJECTABLE DRUG DELIVERY MARKET
13.2.1. GERMANY INJECTABLE DRUG DELIVERY MARKET
13.2.2. FRANCE INJECTABLE DRUG DELIVERY MARKET
13.2.3. UK INJECTABLE DRUG DELIVERY MARKET
13.2.4. ITALY INJECTABLE DRUG DELIVERY MARKET
13.2.5. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET
13.2.6. SPAIN INJECTABLE DRUG DELIVERY MARKET
13.2.7. NETHERLAND INJECTABLE DRUG DELIVERY MARKET
13.2.8. RUSSIA INJECTABLE DRUG DELIVERY MARKET
13.2.9. TURKEY INJECTABLE DRUG DELIVERY MARKET
13.2.10. BELGIUM INJECTABLE DRUG DELIVERY MARKET
13.2.11. REST OF EUROPE INJECTABLE DRUG DELIVERY MARKET
14. EUROPE INJECTABLE DRUG DELIVERY MARKET, COMPANY SHARE
14.1. COMPANY SHARE ANALYSIS: EUROPE
15. COMPANY PROFILES
15.1. BECTON, DICKINSON AND COMPANY
15.1.1. COMPANY OVERVIEW
15.1.1.1. DRIVERS EXPLAINED
15.1.1.2. WEAKNESSES EXPLAINED
15.1.1.3. OPPURTUNITIES EXPLAINED
15.1.1.4. THREATS EXPLAINED
15.1.2. PRODUCT PORTFOLIO
15.1.3. RECENT DEVELOPMENTS
15.2. PFIZER
15.2.1. COMPANY OVERVIEW
15.2.1.1. DRIVERS EXPLAINED
15.2.1.2. WEAKNESSES EXPLAINED
15.2.1.3. OPPURTUNITIES EXPLAINED
15.2.1.4. THREATS EXPLAINED
15.2.2. PRODUCT PORTFOLIO
15.2.3. RECENT DEVELOPMENTS
15.3. BAXTER INTERNATIONAL
15.3.1. COMPANY OVERVIEW
15.3.1.1. DRIVERS EXPLAINED
15.3.1.2. WEAKNESSES EXPLAINED
15.3.1.3. OPPURTUNITIES EXPLAINED
15.3.1.4. THREATS EXPLAINED
15.3.2. PRODUCT PORTFOLIO
15.3.3. RECENT DEVELOPMENTS
15.4. GERRESHEIMER AG
15.4.1. COMPANY OVERVIEW
15.4.2. PRODUCT PORTFOLIO
15.4.3. RECENT DEVELOPMENTS
15.5. SCHOTT AG INC.
15.5.1. COMPANY OVERVIEW
15.5.2. PRODUCT PORTFOLIO
15.5.3. RECENT DEVELOPMENTS
15.6. ALKERMES INC.
15.6.1. COMPANY OVERVIEW
15.6.2. PRODUCT PORTFOLIO
15.6.3. RECENT DEVELOPMENTS
15.7. ANTARES PHARMA
15.7.1. COMPANY OVERVIEW
15.7.2. PRODUCT PORTFOLIO
15.7.3. RECENT DEVELOPMENTS
15.8. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
15.8.1. COMPANY OVERVIEW
15.8.2. PRODUCT PORTFOLIO
15.8.3. RECENT DEVELOPMENTS
15.9. ELCAM MEDICAL
15.9.1. COMPANY OVERVIEW
15.9.2. PRODUCT PORTFOLIO
15.9.3. RECENT DEVELOPMENTS
15.10. ELI LILLY AND COMPANY
15.10.1. COMPANY OVERVIEW
15.10.1.1. DRIVERS EXPLAINED
15.10.1.2. WEAKNESSES EXPLAINED
15.10.1.3. OPPURTUNITIES EXPLAINED
15.10.1.4. THREATS EXPLAINED
15.10.2. PRODUCT PORTFOLIO
15.10.3. RECENT DEVELOPMENTS
15.11. HASELMEIER
15.11.1. COMPANY OVERVIEW
15.11.2. PRODUCT PORTFOLIO
15.11.3. RECENT DEVELOPMENTS
15.12. MYLAN N.V.
15.12.1. COMPANY OVERVIEW
15.12.2. PRODUCT PORTFOLIO
15.12.3. RECENT DEVELOPMENTS
15.13. NOVO NORDISK
15.13.1. COMPANY OVERVIEW
15.13.2. PRODUCT PORTFOLIO
15.13.3. RECENT DEVELOPMENTS
15.14. OWEN MUMFORD LTD
15.14.1. COMPANY OVERVIEW
15.14.2. PRODUCT PORTFOLIO
15.14.3. RECENT DEVELOPMENTS
15.15. SANDOZ INTERNATIONAL GMBH
15.15.1. COMPANY OVERVIEW
15.15.2. PRODUCT PORTFOLIO
15.15.3. RECENT DEVELOPMENTS
15.16. SANOFI
15.16.1. COMPANY OVERVIEW
15.16.2. PRODUCT PORTFOLIO
15.16.3. RECENT DEVELOPMENTS
15.17. TERUMO CORPORATION
15.17.1. COMPANY OVERVIEW
15.17.2. PRODUCT PORTFOLIO
15.17.3. RECENT DEVELOPMENTS
15.18. TEVA PHARMACEUTICAL
15.18.1. COMPANY OVERVIEW
15.18.1.1. DRIVERS EXPLAINED
15.18.1.2. WEAKNESSES EXPLAINED
15.18.1.3. OPPURTUNITIES EXPLAINED
15.18.1.4. THREATS EXPLAINED
15.18.2. PRODUCT PORTFOLIO
15.18.3. RECENT DEVELOPMENTS
15.19. WEST PHARMACEUTICAL SERVICES, INC
15.19.1. COMPANY OVERVIEW
15.19.2. PRODUCT PORTFOLIO
15.19.3. RECENT DEVELOPMENTS
15.20. YPSOMED HOLDING AG
15.20.1. COMPANY OVERVIEW
15.20.2. PRODUCT PORTFOLIO
15.20.3. RECENT DEVELOPMENTS
16. RELATED REPORTS
Questions? We'll Put You On The Right Path Request Analyst Call: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=europe-injectable-drug-delivery-market
Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want.
Get Discount On This Report To Know More @ https://databridgemarketresearch.com/reports/europe-injectable-drug-delivery-market/
Related Report
Global Injectable Drug Delivery Market – Industry Trends and Forecast to 2024
Global Injectable Drug Delivery Market, By Type (Devices, Formulations), Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User, Geography – Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com